Rapiscan

Medicinal product

(Invented) name

Rapiscan

Active substance (s)

Regadenozonas

Strength

400 µg

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01EB21, Regadenoson

Marketing authorisation holder

GE Healthcare AS, Norvegija

Date of authorisation

2010-09-06

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	5 ml
Regadenozonas	400 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
42628	56396	1056396	flakonas	N1		Receptinis	EU/1/10/643/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-09-06	Registruotas